BioNexus Gene Lab Corp (NASDAQ: BGLC) Stock Information | RedChip

BioNexus Gene Lab Corp (NASDAQ: BGLC) Listen to this Section


$0.41
-0.0307 ( -6.95% ) 94.8K

BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.

Market Data


Open


$0.41

Previous close


$0.44

Volume


94.8K

Market cap


$7.41M

Day range


$0.40 - $0.45

52 week range


$0.31 - $3.39

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 68 Aug 14, 2024
8-k/a 8K-related 20 Jul 05, 2024
10-q/a Quarterly Reports 16 May 31, 2024
10-q/a Quarterly Reports 16 May 31, 2024
10-k/a Quarterly Reports 16 May 31, 2024
10-k/a Quarterly Reports 16 May 31, 2024
10-q/a Quarterly Reports 16 May 31, 2024
10-q Quarterly Reports 68 May 15, 2024
8-k 8K-related 15 May 09, 2024
8-k 8K-related 17 Apr 18, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.